Full results can be seen after 1 year, provided a healthy lifestyle is maintained
The Pharmacy Compounding Advisory Committee met to evaluate seven restricted peptides for specific uses:2 BPC-157 for ulcerative colitis TB-500 for wound-healing KPV for wound-healing and inflammation MOTS-c for obesity and osteoporosis Epitalon for insomnia Semax for cerebral ischemia, migraine, and trigeminal neuralgia Emideltide (DSIP) for opioid withdrawal, chronic insomnia, and narcolepsy The committee voted in favor of lifting restrictions on only the first six
DOI: 10.1056/NEJMoa1800389 Guasch-Ferre, M., Pacheco, L.S., Tessier, A.J., et al
Compounded semaglutide in vial form requires reconstitution similar to sermorelin
The efficacy of GIP/GLP1 receptor co-agonists on glucose control is surprising, and allows to reach glucose levels similar to diabetes remission in a greater percentage of patients compared to other treatments